Harness the power of eCOA in your next trial
Webinar

REGISTER

How implementing an eCOA increases trial efficiencies and provides real-time insights

As the healthcare landscape rapidly shifts to a more patient-centric approach, pharma companies are adopting technology within their studies to better meet patient needs. Electronic clinical outcome assessments (eCOAs) are a key tool to not only ensure each patient is at the center of care, but also to increase operational efficiencies, data integrity, regulatory compliance, and more.

In this webinar, IQVIA eCOA leaders Kris Gustafson and Anthony Mikulaschek explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them. Also, IQVIA’s eCOA solution design manager, Melissa Mooney, will share key considerations for implementing eCOAs into studies. Specific points will include:
  • Understanding the forcing factors that are pushing life science companies to make the switch from paper diaries
  • The importance eCOAs have on the decentralized trials landscape
  • How your study can benefit from implementing an eCOA
  • Considerations for operationalizing eCOA in your next study
Key take-aways for attendees include:
  • How you can maximize your efficiencies in the deployment of eCOA(s) in your study
  • How eCOAs provide real-time insights that inform trial progress and demonstrate results
  • A clearer understanding of how to define an implementation strategy for eCOAs in your next study

Link for on-demand webinar

Speakers

Kris Gustafson
Vice President and Global Head IQVIA eCOA
IQVIA
Anthony Mikulaschek
eCOA Operations Lead
IQVIA
Melissa Mooney
eCOA Solution Design Manager
IQVIA

Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in ourtoll-free list.

Media Inquiries

Please use this form to reach out to our media team with inquiries. Thank you.